table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID 19 hospitalizedCOVID-19 mild to moderate
Kinase inhibitors
acalabrutinib CALAVI US CALAVI
imatinib Covid-19 HUF

0 studies excluded by filtering options 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons